Trial Information - Phase II
TAPISTRY: TUMOR-AGNOSTIC PRECISION IMMUNOONCOLOGYAND SOMATIC TARGETING RATIONAL FOR YOU (TAPISTRY) PHASE II PLATFORM TRIAL
Disease Specifics: (ROS-1 & ALK) (NTRK1/2/3) (AKT1/2/3) (RET)(TMB High)
Protocol ID: BO41932
Sponsor: Genentech, Inc.
Status: OPEN TO ENROLLMENT
Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at
877-664-7724